M
MPLT
MapLight Therapeutics, Inc.
24.14
+1.53+6.77%Closed19:24 04/07 EDT
OPEN/PREV CLOSE22.76/22.61
TODAY RANGE22.19-24.15
VOL302.57K
MARKET CAP1.05B
52 WEEK RANGE12.24-24.15
AVG VOL (3M)201.33K
% TURNOVER0.69%
TURNOVER--
P/E (TTM)-19.1648
% RANGE8.67%
EPS(TTM)-1.2596
P/E(FORWARD)-6.0050
P/B15.69
BVPS1.539
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP356.06M
SHARES OUTSTANDING43.64M
NEXT EARNINGS06/02-06/12
FREE FLOAT14.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·22h ago
MapLight Therapeutics initiated with a Buy at TD Cowen
NASDAQ·03/26 12:23
MapLight Reports FY25 Results, Expects Multiple Phase 2 Readouts In 2026
Seeking Alpha·03/26 11:49
MapLight Therapeutics, Inc. GAAP EPS of -$2.47
TipRanks·03/26 11:30
MapLight Therapeutics Highlights Growing CNS Pipeline, Strong Cash Position
Benzinga·03/26 11:11
Earnings Scheduled For March 26, 2026
Benzinga·03/26 11:07
MapLight Therapeutics Q4 EPS $(2.47) Misses $(0.96) Estimate
Dow Jones·03/26 11:07
*MapLight Therapeutics: Runway to Fund Operations Through 2027 >MPLT
Dow Jones·03/26 11:02
*MapLight Therapeutics 4Q Loss $79.5M >MPLT
Reuters·03/26 11:00
MAPLIGHT THERAPEUTICS INC - Q4 NET LOSS $79.5 MLN, Q4 EPS $-2.47
Dow Jones·03/26 11:00
Press Release: MapLight Therapeutics Reports -2-
Dow Jones·03/19 13:06
MapLight Therapeutics Price Target Announced at $35.00/Share by Canaccord Genuity
Same Industry
Name/Symbol
Change%
Price